
Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Manual for Mountain Objections on the planet - 2
Outer space conditions hamper sperm's ability to navigate toward an egg - 3
Picking the Right Pot for Your Plants: An Aide for Plant Devotees - 4
Taylor Momsen explains why she quit 'Gossip Girl': 'I really didn't want to be there' - 5
Ultra-Orthodox protests erupt across Israel on haredi IDF enlistment day
One lightly wounded after Iranian missile barrage targets northern Israel
Scientists find evidence that an asteroid contains tryptophan
‘Extraordinary’ Iron Age war trumpet uncovered in England
West Bank man indicted for extortion, impersonation of IAF pilot, Mossad agent, illegal entry
8 Espresso Bean Starting points All over the Planet
4 Energy-Proficient Clothes washers to Consider in 2024
Which Instax Camera Would it be a good idea for you to Purchase?
Ober Gabelhorn glacier reveals remains of man missing for over three decades
'Hero' who wrestled gun from Bondi shooter named as Ahmed al Ahmed












